MapLight Therapeutics (MPLT) Other Gross PP&E Adjustments (2024 - 2025)
MapLight Therapeutics recorded quarterly Other Gross PP&E Adjustments of -$2.3 million in Q4 2025, up 45.86% quarter-over-quarter from -$4.2 million in Q3 2025, and up 27.77% year-over-year from -$1.8 million in Q4 2024.
MapLight Therapeutics' Other Gross PP&E Adjustments history runs 2 years deep, the most recent figure standing at -$2.3 million for Q4 2025.
- In Q4 2025, Other Gross PP&E Adjustments rose 27.77% year-over-year to -$2.3 million; the TTM figure through Dec 2025 stood at -$2.3 million (up 27.77% YoY), while the FY2025 annual figure was -$2.3 million, up 27.77% from the prior year.
- Other Gross PP&E Adjustments came in at -$2.3 million for Q4 2025 at MapLight Therapeutics, up from -$4.2 million in the prior quarter.
- In the past five years, Other Gross PP&E Adjustments ranged from a high of -$2.3 million in Q4 2025 to a low of -$4.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Gross PP&E Adjustments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -83,048.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | -60,691.22 |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -285.20 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -892,000.00 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -1.69 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -189.30 Mn |
| 10 | MapLight Therapeutics | 254.43 Mn | 254.43 Mn | - | -2.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -2.29 Mn |
| Dec 31, 2025 | -2.29 Mn |
| Sep 30, 2025 | -4.23 Mn |
| Sep 30, 2025 | -4.23 Mn |
| Dec 31, 2024 | -3.17 Mn |
| Dec 31, 2024 | -3.17 Mn |